Intellia Therapeutics (NTLA)
(Delayed Data from NSDQ)
$25.79 USD
+1.16 (4.71%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $25.79 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -1.21 |
EPS Last Quarter | -1.06 |
Last EPS Surprise | 21.48% |
ABR | 1.54 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -5.08 |
Next Year | -5.29 |
EPS (TTM) | -5.30 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 20.25M | 13.83M | 82.85M | 87.86M |
# of Estimates | 11 | 9 | 13 | 11 |
High Estimate | 37.78M | 32.69M | 187.60M | 210.00M |
Low Estimate | 5.00M | 4.00M | 43.94M | 9.00M |
Year ago Sales | 13.59M | 11.99M | 36.28M | 82.85M |
Year over Year Growth Est. | 48.97% | 15.38% | 128.39% | 6.06% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.21 | -1.32 | -5.08 | -5.29 |
# of Estimates | 13 | 12 | 14 | 13 |
Most Recent Consensus | -1.35 | -1.45 | -5.45 | -6.38 |
High Estimate | -0.98 | -1.05 | -4.52 | -4.09 |
Low Estimate | -1.42 | -1.54 | -5.68 | -6.38 |
Year ago EPS | -1.40 | -1.38 | -5.42 | -5.08 |
Year over Year Growth Est. | 13.57% | 4.35% | 6.27% | -3.99% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 1 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.21 | -1.32 | -5.08 | -5.29 |
7 Days Ago | -1.21 | -1.32 | -5.08 | -5.26 |
30 Days Ago | -1.21 | -1.32 | -5.10 | -5.28 |
60 Days Ago | -1.23 | -1.33 | -5.15 | -5.30 |
90 Days Ago | -1.31 | -1.40 | -5.58 | -5.51 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.21 | -1.32 | -5.45 | -5.68 |
Zacks Consensus Estimate | -1.21 | -1.32 | -5.08 | -5.29 |
Earnings ESP | 0.00% | 0.00% | -7.22% | -7.37% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.06 | -1.46 | -1.38 | -1.40 | NA |
Estimate | -1.35 | -1.47 | -1.52 | -1.32 | NA |
Difference | 0.29 | 0.01 | 0.14 | -0.08 | 0.09 |
Surprise | 21.48% | 0.68% | 9.21% | -6.06% | 6.33% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more